Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Supplementation with Darbepoetin Alfa in Chemotherapy-Associated Anemia
NCT00661999Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sodium ferric gluconate and ferrous sulfate in anemia (3 arms), sponsored by Mayo Clinic. Primary endpoint: Hematopoietic Response Rate at 16 weeks. Started Jan 2006; status: completed.
02
Drugs
sodium ferric gluconateferrous sulfate
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00661999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661999.